Skip to main content

Advertisement

We’d like to understand how you use our websites in order to improve them. Register your interest.

Correction to: Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial

Correction to: BMC Psychiatry (2019) 19:375

https://doi.org/10.1186/s12888-019-2359-1

After publication of our article [1] we were notified that Fig. 1 was wrongly presented.

Fig. 1
figure1

Trial flowchart. Schematic overview of the study design. T: Number illustrates number of weeks after baseline

The correct figure and corresponding title is presented below:

The original article has been corrected.

Reference

  1. 1.

    Smith-Apeldoorn SY, et al. Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial. BMC Psychiatry. 2019;19:375. https://doi.org/10.1186/s12888-019-2359-1.

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Sanne Y. Smith-Apeldoorn.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Smith-Apeldoorn, S.Y., Veraart, J.K.E., Kamphuis, J. et al. Correction to: Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial. BMC Psychiatry 20, 9 (2020). https://doi.org/10.1186/s12888-019-2398-7

Download citation